Anti-IL-8 抗体
Anti-IL-8 antibody
Be the first to review this product! Submit a review
|
(27 Publications)
Rabbit Polyclonal IL-8 antibody. Suitable for IHC-P, WB and reacts with Human samples. Cited in 27 publications. Immunogen corresponding to Synthetic Peptide within Human CXCL8 aa 50 to C-terminus.
別名を表示する
IL8, CXCL8, Interleukin-8, IL-8, C-X-C motif chemokine 8, Chemokine (C-X-C motif) ligand 8, Emoctakin, Granulocyte chemotactic protein 1, Monocyte-derived neutrophil chemotactic factor, Monocyte-derived neutrophil-activating peptide, Neutrophil-activating protein 1, Protein 3-10C, T-cell chemotactic factor, GCP-1, MDNCF, MONAP, NAP-1
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-IL-8 antibody (AB106350)
IL8 was detected in a paraffin-embedded section of human stomach cancer tissue. Heat mediated antigen retrieval was performed in EDTA buffer (pH 8.0, epitope retrieval solution). The tissue section was blocked with 10% goat serum. The tissue section was then incubated with 2 μg/ml ab106350 overnight at 4°C. Peroxidase Conjugated Goat Anti-rabbit IgG was used as secondary antibody and incubated for 30 minutes at 37°C. The tissue section was developed using a HRP conjugated Rabbit IgG with DAB as the chromogen.
- WB
Supplier Data
Western blot - Anti-IL-8 antibody (AB106350)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
In Western blot, ab322732 and ab106350 were shown to bind specifically to IL-8. Target of interest was observed at 11 kDa in untreated wild-type PC-3 cell lysates (lane 1) and upregulated in treated wild-type PC-3 cell lysates (lane 2). No signal was observed at this size in untreated IL-8 knockout cell line (lane 3) or treated IL-8 knockout cell line (lane 4).
Recombinant multiclonal ab322732 showed higher sensitivity than polyclonal ab106350.
In Western blot, Anti-GAPDH antibody [EPR16891] - Loading Control (ab181602) staining at 1/200000 dilution.
All lanes:
Western blot - Anti-IL-8 antibody [RM1267] (<a href='/products/primary-antibodies/il-8-antibody-rm1267-ab322732'>ab322732</a>) at 1/1000 dilution
Lane 1:
Untreated Wild-type PC-3 (human prostate adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
Wild-type PC-3 treated with2 ug/ml LPS for 1 hour, 5ug/ml Brefeldin A was then added for additional 5 hours, whole cell lysate at 20 µg
Lane 3:
Untreated CXCL8 knockout PC-3 whole cell lysate at 20 µg
Lane 4:
CXCL8 knockout PC-3 treated with 2 ug/ml LPS for 1 hour, 5ug/ml Brefeldin A was then added for additional 5 hours, whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 11 kDa,36 kDa
false
Exposure time: 180s
- WB
Supplier Data
Western blot - Anti-IL-8 antibody (AB106350)
All lanes:
Western blot - Anti-IL-8 antibody (ab106350) at 0.5 µg/mL
All lanes:
Recombinant human IL8 protein at 10 ng
Secondary
All lanes:
Goat anti-rabbit IgG-HRP at 1/5000 dilution
false
- WB
CiteAb
Western blot - Anti-IL-8 antibody (AB106350)
Western Blotting using Anti-IL-8 antibody, ab106350. Publication image from Allouch, A. et al., 2022, Nat Commun, 36347876. Legend direct from paper.
Tumor cell phagocytosis triggers the proinflammatory activation of macrophages.a Schematic representation of the coculture of CMFDA-labeled MDMs with CMTMR-labeled malignant hematologic cells. b Confocal micrograph of MDMs and Jurkat cells after 8 h of coculture. c, d Percentage of phagocytosis of leukemia cells or PBLs (c) or CD34+ AML cells (d) in control (Co.)- or ZVAD (100 µM)-treated cocultures. e FACS dot plot of Phago+ MDMs or Phago- MDMs sorted after 2 h of coculture with MOLT4 cells. f, g Confocal micrographs and percentages of CMTMR+CMFDA+ MDMs at 2 h (**p = 0.0079) (f, g) and 96 h (h, i) after Phago+ MDMs and Phago- MDMs sorting. j–n Phago+ MDMs were analyzed in comparison to Phago- MDMs to characterize modulated genes by a microarray (**p = 0.0022, *p = 0.0152) (j), CD163 membrane expression by FACS (**p = 0.0039) (k), and IRF5 expression by western blot (WB) analysis (l) and the supernatant (SN) was evaluated for indicated proinflammatory cytokines by WB analysis (l) or for IFNγ by a cytokine microarray (*p = 0.0286) (m) or ELISA (***p = 0.0008) (n) at 96 h (j, k, m) and 7 d (l, n) after FACS sorting. o, p Transwell coculture model of Phago+ MDMs and Phago- MDMs at 2 h after FACS sorting (o), and iNOS expression identified by WB analysis of Phago- MDMs cocultured in the bottom chambers for 15 d (p). In b, l, p and e, f, h, the data are representative of n = 3 and n = 5 donors. In c, n, d, and g, i, the data are presented as the mean±SEM from n = 3, n = 6, and n = 5 donors. In d, the CD34+ cells were from n = 4 AML patients. In j, box plots show centre line as median, box limits as upper and lower quartiles, and whiskers as a minimum to maximum values, from n = 3 donors. In k and m, the data are donor matched from n = 9 and n = 4 donors. Exact p-values are indicated and determined with two- (g) or one-tailed (m) unpaired Mann-Whitney test, the Kolmogorov–Smirnov test (j), a two-tailed paired Wilcoxon test (k), and a two-tailed unpaired t test (n). Source data are provided as a Source Data file.
false
Reactivity data
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
IL-8 functions as a chemoattractant for neutrophils and lymphocytes facilitating their movement towards the site of infection or injury. It does not form part of a larger protein complex but operates individually to enhance immune cell migration. IL-8 possesses unique binding motifs allowing it to interact with specific receptors namely CXCR1 and CXCR2 on target cells. This binding triggers cellular responses leading to effective immune surveillance and response to inflammatory stimuli.
Pathways
IL-8 operates within important inflammatory and immune response pathways. It forms a part of the NF-κB signaling cascade which activates in response to stress signals promoting the expression of other inflammatory mediators. Additionally it engages in the mitogen-activated protein kinase (MAPK) pathway influencing cellular responses such as proliferation and differentiation. The interaction of IL-8 with these pathways highlights its role in modulating immune responses and highlights its interaction with other proteins such as TNF-α and IL-1β.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (27)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:4128 PubMed40319089
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancer immunology, immunotherapy : CII 74:47 PubMed39751958
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cells 13: PubMed39451241
2024
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell reviews and reports 20:1954-1970 PubMed39028417
2024
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 9:e17315 PubMed37539258
2023
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 8: PubMed37192004
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of dermatology 50:1150-1155 PubMed37288510
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:6739 PubMed36347876
2022
Applications
Unspecified application
Species
Unspecified reactive species
Pathology, research and practice 238:154076 PubMed36055087
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 8:235 PubMed35487914
2022
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com